CD8+ T cell immunity to 2009 pandemic and seasonal H1N1 influenza viruses

Vaccine

Volumn 29, Issue 11, 2011, Pages 2159-2168

  Scheible, Kristin ^a   Zhang, Gang ^a   Baer, Jane ^a   Azadniv, Mitra ^a   Lambert, Kris ^a   Pryhuber, Gloria ^a   Treanor, John J ^a   Topham, David J ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

CD8 T cell; Cross protective immunity; Heterosubtypic; Influenza; Multifunctional

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; HEMAGGLUTINATION INHIBITION TEST; HUMAN; INFLUENZA VIRUS A H1N1; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL;

ADULT; ANTIBODIES, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; CROSS REACTIONS; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; IMMUNITY, CELLULAR; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; PANDEMICS; YOUNG ADULT;

EID: 79951810738     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.12.073     Document Type: Article

References (56)

1. Miller 3rd RR, Markewitz BA, Rolfs RT, Brown SM, Dascomb KK, Grissom CK, et al. Clinical findings and demographic factors associated with ICU admission in Utah due to novel 2009 influenza A(H1N1) infection. Chest 2010; 137:752-8.
2. Nin N, Soto L, Hurtado J, Lorente JA, Buroni M, Arancibia F, et al. Clinical characteristics and outcomes of patients with 2009 influenza A(H1N1) virus infection with respiratory failure requiring mechanical ventilation. J Crit Care 2010; doi:10.1016/j.jcrc.2010.05.031.
3. Presanis A.M., De Angelis D., Hagy A., Reed C., Riley S., Cooper B.S., et al. The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis. PLoS Med 2009, 6:e1000207.
4. Reed C., Angulo F.J., Swerdlow D.L., Lipsitch M., Meltzer M.I., Jernigan D., et al. Estimates of the prevalence of pandemic (H1N1) 2009, United States, April-July 2009. Emerg Infect Dis 2009, 15:2004-2007.
5. Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, Uyeki TM, et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2010; 362:1708-19.
6. Hancock K., Veguilla V., Lu X., Zhong W., Butler E.N., Sun H., et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009, 361:1945-1952.
7. Chen G.L., Subbarao K. Attacking the flu: neutralizing antibodies may lead to 'universal' vaccine. Nat Med 2009, 15:1251-1252.
8. Hammitt L.L., Bartlett J.P., Li S., Rahkola J., Lang N., Janoff E.N., et al. Kinetics of viral shedding and immune responses in adults following administration of cold-adapted influenza vaccine. Vaccine 2009, 27:7359-7366.
9. Kreijtz J.H., de Mutsert G., van Baalen C.A., Fouchier R.A., Osterhaus A.D., Rimmelzwaan G.F. Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus. J Virol 2008, 82:5161-5166.
10. Rizzo C, Rota MC, Bella A, Alfonsi V, Declich S, Caporali MG, et al. Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period. Vaccine 2010; 28:3558-62.
11. Treanor J., Wu H., Liang H., Topham D.J. Immune responses to vaccinia and influenza elicited during primary versus recent or distant secondary smallpox vaccination of adults. Vaccine 2006, 24:6913-6923.
12. van Riet E., Adegnika A.A., Retra K., Vieira R., Tielens A.G., Lell B., et al. Cellular and humoral responses to influenza in gabonese children living in rural and semi-urban areas. J Infect Dis 2007, 196:1671-1678.
13. Boon A.C., Fringuelli E., Graus Y.M., Fouchier R.A., Sintnicolaas K., Iorio A.M., et al. Influenza A virus specific T cell immunity in humans during aging. Virology 2002, 299:100-108.
14. Wahl A., Schafer F., Bardet W., Buchli R., Air G.M., Hildebrand W.H. HLA class I molecules consistently present internal influenza epitopes. Proc Natl Acad Sci USA 2009, 106:540-545.
15. Garten R.J., Davis C.T., Russell C.A., Shu B., Lindstrom S., Balish A., et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009, 325:197-201.
16. De Groot A.S., Ardito M., McClaine E.M., Moise L., Martin W.D. Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008-2009 conventional influenza vaccine. Vaccine 2009, 27:5740-5747.
17. Greenbaum J.A., Kotturi M.F., Kim Y., Oseroff C., Vaughan K., Salimi N., et al. Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc Natl Acad Sci USA 2009, 106:20365-20370.
18. Xing Z., Cardona C.J. Preexisting immunity to pandemic (H1N1) 2009. Emerg Infect Dis 2009, 15:1847-1849.
19. Noble G.R., Kaye H.S., Yarbrough W.B., Fiedler B.K., Reed C.J., Felker M.B., et al. Measurement of hemagglutination-inhibiting antibody to influenza virus in the 1976 influenza vaccine program: methods and test reproducibility. J Infect Dis 1977, 136 Suppl:S429-S434.
20. Lamoreaux L., Roederer M., Koup R. Intracellular cytokine optimization and standard operating procedure. Nat Protoc 2006, 1:1507-1516.
21. O'brien RA Tour of UnifyPow: A SAS Macro for sample-size analysis. Proceedings of the 23rd SAS Users Group International Conference Cary NC 1998, 1346-1355. SAS Institute.
22. Team R.D.C. R: A language and environment for statistical computing 2008, R Foundation for Statistical Computing, Vienna, Austria.
23. Erickson A.L., Willberg C.B., McMahan V., Liu A., Buchbinder S.P., Grohskopf L.A., et al. Potentially exposed but uninfected individuals produce cytotoxic and polyfunctional human immunodeficiency virus type 1-specific CD8(+) T-cell responses which can be defined to the epitope level. Clin Vaccine Immunol 2008, 15:1745-1748.
24. Gaucher D., Therrien R., Kettaf N., Angermann B.R., Boucher G., Filali-Mouhim A., et al. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J Exp Med 2008, 205:3119-3131.
25. Lin Y., Gallardo H.F., Ku G.Y., Li H., Manukian G., Rasalan T.S., et al. Optimization and validation of a robust human T-cell culture method for monitoring phenotypic and polyfunctional antigen-specific CD4 and CD8 T-cell responses. Cytotherapy 2009, 11:912-922.
26. Ndhlovu ZM, Oelke M, Schneck JP, Griffin DE. Dynamic regulation of functionally distinct virus-specific T cells. Proc Natl Acad Sci USA 2010; 107:3669-74.
27. Rodrigue-Gervais IG, Rigsby H, Jouan L, Sauve D, Sekaly RP, Willems B, et al. Dendritic cell inhibition is connected to exhaustion of CD8+ T cell polyfunctionality during chronic hepatitis C virus infection. J Immunol 2010; 184:3134-44.
28. Li C.K., Wu H., Yan H., Ma S., Wang L., Zhang M., et al. T cell responses to whole SARS coronavirus in humans. J Immunol 2008, 181:5490-5500.
29. Manigold T., Mori A., Graumann R., Llop E., Simon V., Ferres M., et al. Highly differentiated, resting gn-specific memory CD8+ T cells persist years after infection by andes hantavirus. PLoS Pathog 2010, 6:e1000779.
30. Makedonas G., Hutnick N., Haney D., Amick A.C., Gardner J., Cosma G., et al. Perforin and IL-2 upregulation define qualitative differences among highly functional virus-specific human CD8 T cells. PLoS Pathog 2010, 6:e1000798.
31. Kaech S.M., Wherry E.J. Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection. Immunity 2007, 27:393-405.
32. Harty J.T., Badovinac V.P. Shaping and reshaping CD8+ T-cell memory. Nat Rev Immunol 2008, 8:107-119.
33. Prlic M., Bevan M.J. Exploring regulatory mechanisms of CD8+ T cell contraction. Proc Natl Acad Sci USA 2008, 105:16689-16694.
34. Darrah P.A., Patel D.T., De Luca P.M., Lindsay R.W., Davey D.F., et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 2007, 13:843-850.
35. Seder R.A., Darrah P.A., Roederer M. T-cell quality in memory and protection: implications for vaccine design. Nat Rev Immunol 2008, 8:247-258.
36. Shooshtari P., Fortuno E.S., Blimkie D., Yu M., Gupta A., Kollmann T.R., et al. Correlation analysis of intracellular and secreted cytokines via the generalized integrated mean fluorescence intensity. Cytometry 2010, A77:873-880.
37. Furuya Y, Chan J, Regner M, Lobigs M, Koskinen A, Kok T, et al. Cytotoxic T cells are the predominant players providing cross-protective immunity induced by {gamma}-irradiated influenza A viruses. J Virol 2010; 84:4212-21.
38. Schotsaert M., Ibanez L.I., Fiers W., Saelens X. Controlling influenza by cytotoxic T-cells: calling for help from destroyers. J Biomed Biotechnol. 2010, 2010:863985.
39. Epstein S.L. Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature. J Infect Dis 2006, 193:49-53.
40. Grebe K.M., Yewdell J.W., Bennink J.R. Heterosubtypic immunity to influenza A virus: where do we stand?. Microbes Infect 2008, 10:1024-1029.
41. Rimmelzwaan G.F., McElhaney J.E. Correlates of protection: novel generations of influenza vaccines. Vaccine 2008, 26(Suppl. 4):D41-D44.
42. Mueller SN, Langley WA, Carnero E, Garcia-Sastre A, Ahmed R. Immunization with live attenuated influenza viruses that express altered NS1 proteins results in potent and protective memory CD8+ T-cell responses. J Virol 2009; 84:1847-55.
43. Rimmelzwaan G.F., Nieuwkoop N., Brandenburg A., Sutter G., Beyer W.E., Maher D., et al. A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM vaccines and conventional vaccines. Vaccine 2000, 19:1180-1187.
44. Toapanta F.R., Ross T.M. Impaired immune responses in the lungs of aged mice following influenza infection. Respir Res 2009, 10:112.
45. Touvrey C., Derre L., Devevre E., Corthesy P., Romero P., Rufer N., et al. Dominant human CD8 T cell clonotypes persist simultaneously as memory and effector cells in memory phase. J Immunol 2009, 182:6718-6726.
46. Tu W, Mao H, Zheng J, Liu Y, Chiu SS, Qin G, et al. Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus. J Virol 2010; 84:6527-35.
47. Rimmelzwaan G.F., Fouchier R.A., Osterhaus A.D. Influenza virus-specific cytotoxic T lymphocytes: a correlate of protection and a basis for vaccine development. Curr Opin Biotechnol 2007, 18:529-536.
48. Shahid Z., Kleppinger A., Gentleman B., Falsey A.R., McElhaney J.E. Clinical and immunologic predictors of influenza illness among vaccinated older adults. Vaccine 2010, 28:6145-6151.
49. McElhaney J.E., Xie D., Hager W.D., Barry M.B., Wang Y., Kleppinger A., et al. T cell responses are better correlates of vaccine protection in the elderly. J Immunol 2006, 176:6333-6339.
50. McElhaney J.E., Ewen C., Zhou X., Kane K.P., Xie D., Hager W.D., et al. Granzyme B: correlates with protection and enhanced CTL response to influenza vaccination in older adults. Vaccine 2009, 27:2418-2425.
51. Kreijtz J.H., Bodewes R., van Amerongen G., Kuiken T., Fouchier R.A., Osterhaus A.D., et al. Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice. Vaccine 2007, 25:612-620.
52. Guo H., Santiago F., Lambert K., Takimoto T., Topham D. T cell mediated protection against lethal 2009 pandemic H1N1 influenza infection in a mouse model. J Virol 2011, 85:448-455.
53. Carrat F., Vergu E., Ferguson N.M., Lemaitre M., Cauchemez S., Leach S., et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 2008, 167:775-785.
54. Monto A.S., Koopman J.S., Longini I.M. Tecumseh study of illness XIII. Influenza infection and disease, 1976-1981. Am J Epidemiol 1985, 121:811-822.
55. Godoy-Ramirez K., Franck K., Mahdavifar S., Andersson L., Gaines H. Optimum culture conditions for specific and nonspecific activation of whole blood and PBMC for intracellular cytokine assessment by flow cytometry. J Immunol Methods 2004, 292:1-15.
56. Lawrence C.W., Ream R.M., Braciale T.J. Frequency, specificity, and sites of expansion of CD8+ T cells during primary pulmonary influenza virus infection. J Immunol 2005, 174:5332-5340.